Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial (Q48580401)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

adaptive radiation therapy

0 references

phase III clinical trial

0 references

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

object named as

Eleanor Walsh

4

0 references

object named as

Emma L Turner

7

0 references

object named as

Tim J Peters

10

0 references

Richard M Martin

object named as

Richard M Martin

11

0 references

0 references

Jenny L Donovan

2

object named as

Jenny L Donovan

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

13

object named as

Freddie C Hamdy

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

5

object named as

Daniel Dedman

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

ProtecT study group

14

object named as

ProtecT study group

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

author name string

J Athene Lane

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Michael Davis

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Liz Down

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Malcolm D Mason

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Chris Metcalfe

9

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

publication date

19 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

15

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

10

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

1109-1118

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus observation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a complex intervention improved randomization and informed consent in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality control of radical prostatectomy: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sexual dysfunction in men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple testing in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporating prognostic factors into causal estimators: a comparison of methods for randomised controlled trials with a time-to-event outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be diffic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70361-4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48580401&oldid=2202193652"